摘要Objectives. To observe the effect of basic fibroblast growth factor (bFGF) slow-release microcapsules on angiogenesis in infarcted myocardial regions.Methods. Myocardial infarction was induced in 24 New Zealand rabbits by ligating the root of left anterior descending coronary artery. Group Ⅰ (n = 8) served as control, group Ⅱ (n = 8) as a blank microcapsule group, group Ⅲ (n = 8, each microcapsule contains lμg bFGF) as micrpcapsule group. In group Ⅱ and Ⅲ, 5 blank microcapsules or bFGF slow-release microcapsules were implanted into myocardium underneath the epicardium between the left antefior descending coronary artery and left circumflex artery. Infarct size was evaluated by infarcted weight/left ventricle weight ratio and angiogenesis was evaluated by immunohistochemical examinations 5 weeks later.Results. As compared with group Ⅰ and Ⅱ, rabbits treated with bFGF slow-release microcapsules showed higher microvessel counts (group Ⅰ 37.75 + 4.50, group Ⅱ 38.37 ± 4.98, vs. group Ⅲ 135.50 ± 4.81, P ＜ 0. 001 ) and less infarcted weight/left ventricle weight (group Ⅰ 16.8% ± 0.4%, group Ⅱ 16.7% ± 0.5%, vs. group Ⅲ 7.0% ±0.2% ,P＜ 0.001).Conclusions. Subepicardial administration of bFGF slow-release microcapsule in the infarcted rabbit model results in effective angiogenesis and reduction in infarct size.